Strategic Business Analyst M H/F - 75

At Robeauté we are developing a really small microrobot for novel therapies in hard-to-reach areas of the body.

Designed specifically for the brain, at the service of neurosurgeons, our microrobot will be able to freely navigate in other complex regions of the body to perform biopsies, collect precise anatomically localized data and deliver therapies on site, at the right dosage.

We are accompanying a major shift from robotic surgery to microrobotic surgery, for greater precision, better results and bold new therapies to tackle global diseases affecting more than a billion people worldwide.

Our microrobot will light a spark in the minds of medical practitioners and scientists around the world, allowing them to imagine and create more effective treatments, to be delivered locally.

We are a pluridisciplinary and multicultural team of passionate, skilled, supportive and creative people, at the crossroads of microrobotics, engineering and medicine. We work with phenomenal medical centers and university labs in Europe and the United States.

Our team is growing and we are constantly on the lookout for highly-talented individuals. Working with us means working on something that has never been done before, so you will be challenged - and you will be supported.

We are team players, with both classical and atypical backgrounds, so unconventional thinking is welcome and good communication skills are a must.

We are based in Paris, France.Strategic Business Analyst

Robeauté is redefining the future of neurosurgery with self-propelled microrobots designed to navigate the human brain with unprecedented precision. Our technology makes it possible to reach deep brain regions that were previously inaccessible, without invasive surgery.

We've developed microrobots capable of travelling inside the brain to collect biopsies, deliver cancer drugs, and implant electrodes for neurological treatments.

Since our founding in 2017, we've filed 50+ patents and successfully tested our technology in living animals, with human clinical trials targeted for 2026. We recently raised €27M in Series A funding from Plural, Cherry Ventures, Kindred Ventures, and Brainlab, fueling our next phase of growth.

As we scale, we are looking for aStrategic Business Analystto drive investor-facing analysis, business performance insights, and market segmentation strategies that support our growth and strategic decision-making.

What you'll do

Strategic Financial Analysis

- Build and maintain robust financial models to support fundraising activities, investor reporting, and long-term strategic planning.
- Prepare high-quality investor materials, including pitch decks and financial presentations.
- Analyze valuation benchmarks, funding trends, and investor expectations within deeptech and MedTech sectors.
- Collaborate closely with executive leadership to align financial narratives with Robeauté's overall strategic vision.
- Structure licensing agreements and develop comprehensive business models to support partnership and commercialization strategies.

Business Performance & Decision Support

- Design and implement dashboards and performance reports to enable data-driven decision-making across product, operations, and finance.
- Identify growth levers and operational efficiencies through advanced analytics and actionable insights.
- Support budgeting, forecasting, and scenario planning to ensure financial resilience and adaptability.

Market Intelligence & Segmentation

- Conduct in-depth market research to identify emerging trends, growth opportunities, and competitive dynamics.
- Segment customer and stakeholder profiles to inform go-to-market strategies and product positioning.
- Benchmark competitors on pricing, positioning, and innovation to maintain a competitive edge.
- Translate market insights into actionable recommendations for leadership and product development teams.